Glycosylation of sputum mucins is altered in cystic fibrosis patients

Glycobiology

Volumn 17, Issue 7, 2007, Pages 698-712

  Schulz, Benjamin L ^a   Sloane, Andrew J ^a   Robinson, Leanne J ^a   Prasad, Sindhu S ^a   Lindner, Robyn A ^a   Robinson, Michael ^b   Bye, Peter T ^b   Nielson, Dennis W ^c   Harry, Jenny L ^a   Packer, Nicolle H ^a   Karlsson, Niclas G ^a  

^a Proteome Systems Ltd   (Australia)

^b ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cystic fibrosis; Mass spectrometry; Mucin; O glycosylation; Pulmonary exacerbation

Indexed keywords

BIOLOGICAL MARKER; GLYCOPROTEIN; MUCIN 5AC; MUCIN 5B;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FUCOSYLATION; HOSPITALIZATION; HUMAN; LUNG FIBROSIS; LUNG FUNCTION; MALE; MOLECULAR WEIGHT; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN GLYCOSYLATION; PROTEIN STRUCTURE; SIALYLATION; SPUTUM ANALYSIS; SULFATION;

ADOLESCENT; ADULT; BIOLOGICAL MARKERS; CHILD; CYSTIC FIBROSIS; FEMALE; GLYCOSYLATION; HUMANS; LUNG; MALE; MASS SPECTROMETRY; MUCINS; SPUTUM;

EID: 34447345699     PISSN: 09596658     EISSN: 14602423     Source Type: Journal    
DOI: 10.1093/glycob/cwm036     Document Type: Article

References (47)

1. Boat TF, Cheng PW, Iyer RN, Carlson DM, Polony I. 1976. Human respiratory tract secretion. Mucous glycoproteins of nonpurulent tracheobronchial secretions, and sputum of patients with bronchitis and cystic fibrosis. Arch Biochem Biophys. 177:95-104.
2. Carnoy C, Ramphal R, Scharfman A, Lo-Guidice JM, Houdret N, Klein A, Galabert C, Lamblin G, Roussel P. 1993. Altered carbohydrate composition of salivary mucins from patients with cystic fibrosis and the adhesion of Pseudomonas aeruginosa. Am J Respir Cell Mol Biol. 9:323-334.
3. Chace KV, Flux M, Sachdev GP. 1985. Comparison of physicochemical properties of purified mucus glycoproteins isolated from respiratory secretions of cystic fibrosis and asthmatic patients. Biochemistry. 24:7334-7341.
4. Chace KV, Leahy DS, Martin R, Carubelli R, Flux M, Sachdev GP. 1983. Respiratory mucous secretions in patients with cystic fibrosis: relationship between levels of highly sulfated mucin component and severity of the disease. Clin Chim Acta. 132:143-155.
5. Cheng PW, Boat TF, Cranfill K, Yankaskas JR, Boucher RC. 1989. Increased sulfation of glycoconjugates by cultured nasal epithelial cells from patients with cystic fibrosis. J Clin Invest. 84:68-72.
6. Dakin C, Henry RL, Field P, Morton J. 2001. Defining an exacerbation of pulmonary disease in cystic fibrosis. Pediatr Pulmonol. 31:436-442.
7. Davril M, Degroote S, Humbert P, Galabert C, Dumur V, Lafitte JJ, Lamblin G, Roussel P. 1999. The sialylation of bronchial mucins secreted by patients suffering from cystic fibrosis or from chronic bronchitis is related to the severity of airway infection. Glycobiology. 9:311-321.
8. Fahy JV, Kim KW, Liu J, Boushey HA. 1995. Prominent neutrophilic inflammation in sputum from subjects with asthma exacerbation. J Allergy Clin Immunol. 95:843-852.
9. Frates RC Jr, Kaizu TT, Last JA. 1983. Mucus glycoproteins secreted by respiratory epithelial tissue from cystic fibrosis patients. Pediatr Res. 17: 30-34.
10. Gagneux P, Cheriyan M, Hurtado-Ziola N, van der Linden EC, Anderson D, McClure H, Varki A, Varki NM. 2003. Human-specific regulation of alpha 2-6-linked sialic acids. J Biol Chem. 278:48245-48250.
11. Gershman NH, Wong HH, Liu JT, Mahlmeister MJ, Fahy JV. 1996. Comparison of two methods of collecting induced sputum in asthmatic subjects. Eur Respir J. 9:2448-2453.
12. Gibson RL, Burns JL, Ramsey BW. 2003. Pathophysiology and management of pulmonary infections in cystic fibrosis. Am J Respir Crit Care Med. 168:918-951.
13. Glick MC, Kothari VA, Liu A, Stoykova LI, Scanlin TF. 2001. Activity of fucosyltransferases and altered glycosylation in cystic fibrosis airway epithelial cells. Biochimie. 83:743-747.
14. Grinyer J, McKay M, Nevalainen H, Herbert BR. 2004. Fungal proteomics: initial mapping of biological control strain Trichoderma harzianum Curr Genet. 2004:163-169.
15. Helbich TH, Heinz-Peer G, Fleischmann D, Wojnarowski C, Wunderbaldinger P, Huber S, Eichler I, Herold CJ. 1999. Evolution of CT findings in patients with cystic fibrosis. AJR Am J Roentgenol. 173: 81-88.
16. Hill WG, Harper GS, Rozaklis T, Boucher RC, Hopwood JJ. 1997. Organ-specific over-sulfation of glycosaminoglycans and altered extracellular matrix in a mouse model of cystic fibrosis. Biochem Mol Med. 62: 113-122.
17. Holmen JM, Karlsson NG, Abdullah LH, Randell SH, Sheehan JK, Hansson GC, Davis CW. 2004. Mucins and their O-glycans from human bronchial epithelial cell cultures. Am J Physiol Lung Cell Mol Physiol. 287:L824-834.
18. Jayaraman S, Joo NS, Reitz B, Wine JJ, Verkman AS. 2001. Submucosal gland secretions in airways from cystic fibrosis patients have normal [Na(+)] and pH but elevated viscosity. Proc Natl Acad Sci USA. 98:8119-8123.
19. Jiang X, Hill WG, Pilewski JM, Weisz OA. 1997. Glycosylation differences between a cystic fibrosis and rescued airway cell line are not CFTR dependent. Am J Physiol. 273:L913-920.
20. Joo NS, Irokawa T, Robbins RC, Wine JJ. 2006. Hyposecretion, not hyperabsorption, is the basic defect of cystic fibrosis airway glands. J Biol Chem. 281:7392-7398.
21. Joshi HJ, Harrison MJ, Schulz BL, Cooper CA, Packer NH, Karlsson NG. 2004. Developent of a mass fingerprinting tool for automated interpretation of oligosaccharide fragmentation data. Proteomics. 4:1650-1664.
22. Karlsson NG, Wilson NL, Wirth HJ, Dawes P, Joshi H, Packer NH. 2004. Negative ion graphitised carbon nano-liquid chromatography/mass spectrometry increases sensitivity for glycoprotein oligosaccharide analysis. Rapid Commun Mass Spectrom. 18:2282-2292.
23. Konstan MW, Davis PB. 2002. Pharmacological approaches for the discovery and development of new anti-inflammatory agents for the treatment of cystic fibrosis. Adv Drug Deliv Rev. 54:1409-1423.
24. Kube D, Adams L, Perez A, Davis PB. 2001. Terminal sialylation is altered in airway cells with impaired CFTR-mediated chloride transport. Am J Physiol Lung Cell Mol Physiol. 280:L482-492.
25. Lamblin G, Degroote S, Perini JM, Delmotte P, Scharfman AE, Davril M, Lo-Guidice JM, Houdret N, Dumur V, Klein A, Roussel P. 2001. Human airway mucin glycosylation: A combinatory of carbohydrate determinants which vary in cystic fibrosis. Glycoconj J. 18:661-684.
26. Lamblin G, Lhermitte M, Lafitte JJ, Filliat M, Degand P, Roussel P. 1977. Comparative study of bronchial mucins isolated from the sputum of patients suffering from cystic fibrosis or other chronic bronchial diseases. Bull Eur Physiopathol Respir. 13:175-190.
27. Leir SH, Parry S, Palmai-Pallag T, Evans J, Morris HR, Dell A, Harris A. 2005. Mucin glycosylation and sulphation in airway epithelial cells is not influenced by cystic fibrosis transmembrane conductance regulator expression. Am J Respir Cell Mol Biol. 32:453-461.
28. Liou TG, Adler FR, Fitzsimmons SC, Cahill BC, Hibbs JR, Marshall BC. 2001. Predictive 5-year survivorship model of cystic fibrosis. Am J Epidemiol. 153:345-352.
29. Lowe JB. 2002. Glycosylation in the control of selectin counter-receptor structure and function. Immunol Rev. 186:19-36.
30. Mendicino J, Sangadala S. 1999. Synthesis of sulfated oligosaccharides by cystic fibrosis trachea epithelial cells. Mol Cell Biochem. 201:141-149.
31. Ramphal R, Arora SK. 2001. Recognition of mucin components by Pseudomonas aeruginosa. Glycoconj J. 18:709-713.
32. Reid CJ, Burdick MD, Hollingsworth MA, Harris A. 1999. CFTR expression does not influence glycosylation of an epitope-tagged MUC1 mucin in colon carcinoma cell lines. Glycobiology. 9:389-398.
33. Rhim AD, Kothari VA, Park PJ, Mulberg AE, Glick MC, Scanlin TF. 2000. Terminal glycosylation of cystic fibrosis airway epithelial cells. Glycoconj J. 17:385-391.
34. Rosenfeld M, Emerson J, Williams-Warren J, Pepe M, Smith A, Montgomery AB, Ramsey B. 2001. Defining a pulmonary exacerbation in cystic fibrosis. J Pediatr. 139:359-365.
35. Saiman L, Prince A. 1993. Pseudomonas aeruginosa pili bind to asialoGM1 which is increased on the surface of cystic fibrosis epithelial cells. J Clin Invest. 92:1875-1880.
36. Schulz BL, Packer NH, Karlsson NG. 2002. Small-scale analysis of O-linked oligosaccharides from glycoproteins and mucins separated by gel electrophoresis. Anal Chem. 74:6088-6097.
37. Schulz BL, Sloane AJ, Robinson LJ, Sebastian LT, Glanville AR, Song Y, Verkman AS, Harry JL, Packer NH, Karlsson NG. 2005. Mucin glycosylation changes in cystic fibrosis lung disease are not manifest in submucosal gland secretions. Biochem J. 387:911-919.
38. Shinya K, Ebina M, Yamada S, Ono M, Kasai N, Kawaoka Y. 2006. Avian flu: influenza virus receptors in the human airway. Nature. 440:435-436.
39. Shori DK, Genter T, Hansen J, Koch C, Wyatt H, Kariyawasam HH, Knight RA, Hodson ME, Kalogeridis A, Tsanakas I. 2001. Altered sialyl- and fucosyl-linkage on mucins in cystic fibrosis patients promotes formation of the sialyl-Lewis X determinant on salivary MUC-5B and MUC-7. Pflugers Arch. 443:S55-61.
40. Shori DK, Kariyawasam HH, Knight RA, Hodson ME, Genter T, Hansen J, Koch C, Kalogeridis A. 2001. Sulphation of the salivary mucin MG1 (MUC-5B) is not correlated to the degree of its sialylation and is unaffected by cystic fibrosis. Pflugers Arch. 443:S50-54.
41. Sloane AJ, Lindner RA, Prasad SS, Sebastian LT, Pedersen SK, Robinson M, Bye PT, Nielson DW, Harry JL. 2005. Proteomic analysis of sputum from adults and children with cystic fibrosis and from control subjects. Am J Respir Crit Care Med. 172:1416-1426.
42. Thomsson KA, Hinojosa-Kurtzberg M, Axelsson KA, Domino SE, Lowe JB, Gendler SJ, Hansson GC. 2002. Intestinal mucins from cystic fibrosis mice show increased fucosylation due to an induced Fucalpha1-2 glycosyltransferase. Biochem J. 367:609-616.
43. Tiddens HA. 2002. Detecting early structural lung damage in cystic fibrosis. Pediatr Pulmonol. 34:228-231.
44. Wesley A, Forstner J, Qureshi R, Mantle M, Forstner G. 1983. Human intestinal mucin in cystic fibrosis. Pediatr Res. 17:65-69.
45. Wilson NL, Schulz BL, Karlsson NG, Packer NH. 2002. Sequential analysis of N- and O-linked glycosylation of 2D-PAGE separated glycoproteins. J Proteome Res. 1:521-529.
46. Xia B, Royall JA, Damera G, Sachdev GP, Cummings RD. 2005. Altered O-glycosylation and sulfation of airway mucins associated with cystic fibrosis. Glycobiology. 15:747-775.
47. Zhang Y, Doranz B, Yankaskas JR, Engelhardt JF. 1995. Genotypic analysis of respiratory mucous sulfation defects in cystic fibrosis. J Clin Invest. 96: 2997-3004.